Background—Percutaneous pulmonary valve implantation was introduced in the year 2000
as a nonsurgical treatment for patients with right ventricular outflow tract dysfunction …

Objective: To assess the impact of a percutaneous technique for pulmonary valve
implantation on the conventional surgical valve/conduit approach to right ventricular outflow …

Percutaneous transcatheter interventions for valve replacement or implantation is one of the
most exciting developments in the field of interventional cardiology. Valvular stenosis has …

Aims Dysfunction of valved conduits in the right ventricular outflow tract (RVOT) limits
durability and enforces repeated surgical interventions. We report on our combined two …

Background—Right ventricular outflow tract (RVOT) reconstruction with valved conduits in
infancy and childhood leads to reintervention for pulmonary regurgitation and stenosis in …

Background Transcatheter pulmonary valve implantation is approved for the treatment of
dysfunctional right ventricle to pulmonary artery conduits. However, the literature is limited …

Introduction Percutaneous pulmonary valve implantation is now considered feasible and
safe.“Native” right ventricular outflow tract (RVOT), small diameter conduits (< 16 mm) and …

Due to recurrent right ventricular outflow tract (RVOT) dysfunction, patients with complex
congenital heart disease of the RVOT traditionally require multiple surgical interventions …

Aims Percutaneous pulmonary valve implantation (PPVI) is now an accepted treatment
strategy for right ventricular (RV) outflow tract (RVOT) dysfunction in many European Heart …

Objectives: We report our experience of percutaneous valve insertion in pulmonary position
in humans. Background: Over the past 40 years, prosthetic conduits have been developed to …